Training Program in Immunology and Inflammation

免疫学和炎症培训计划

基本信息

项目摘要

ABSTRACT The Immunology and Inflammation training program at NYU School of Medicine (NYUSoM) provides pre- doctoral and post-doctoral training at the interface between immunology and human disease. The Program trains students and postdoctoral fellows in basic immunology as well as its applications in host- pathogen interactions, autoimmune and inflammatory diseases, and antitumor immunity. A long-term goal of the program is to train a new cadre of researchers in the broad and interdisciplinary area of immunology and its relation to inflammatory processes. The first cycle of the program supported multiple successful trainees, all of whom currently continue training or employment in academic immunology research. The training program currently has 30 faculty who are highly productive scientists with extensive mentoring experience. The faculty mentors all share a common interest in understanding basic immunological mechanisms and how the dysregulation of these mechanisms by genetic and environmental factors leads to disease. In addition, NYUSoM is undertaking a major expansion of its immunology research base at all levels and through multiple departments and centers. To match this existing research strength and ongoing expansion in the field of immunology, we propose a training program with 4 pre-doctoral and 2 post-doctoral positions. The program complements and interacts with other existing training programs at NYUSoM, but provides a unique curriculum and training experience with rigorous courses and seminars in an environment that encourages diversity. Trainees will acquire the ability to critically evaluate scientific data and literature and will develop their writing and presentation skills through participation in the immunology seminar series, work-in-progress presentations, journal clubs and an annual retreat. The successful trainees will represent a new generation of scientists who can contribute to the development of novel therapies to treat inflammatory diseases.
摘要 纽约大学医学院(NYUSoM)的免疫学和炎症培训计划提供了预防性治疗, 在免疫学和人类疾病之间的接口博士和博士后培训。的 该计划培养学生和博士后研究员在基础免疫学以及其在主机中的应用, 病原体相互作用、自身免疫和炎性疾病以及抗肿瘤免疫。长期 该计划的目标是在广泛的跨学科领域培养一批新的研究人员, 免疫学及其与炎症过程的关系。该计划的第一个周期支持 多名成功的学员,他们目前都在继续培训或就业,在学术 免疫学研究。该培训项目目前有30名教师谁是高产科学家 拥有丰富的指导经验。教师导师们都有一个共同的兴趣, 基本的免疫机制,以及这些机制的失调是如何通过遗传和 环境因素导致疾病。此外,NYUSoM正在进行其 免疫学研究基地,各级和通过多个部门和中心。人口的 现有的研究力量和免疫学领域的不断扩大,我们提出了一个培训 该计划有4个博士前和2个博士后职位。该计划补充和互动, 其他现有的培训计划,但提供了一个独特的课程和培训经验 在鼓励多样性的环境中举办严格的课程和研讨会。学员将获得 批判性地评估科学数据和文献的能力,并将发展他们的写作和演讲 通过参加免疫学研讨会系列,正在进行的工作介绍,期刊 俱乐部和年度务虚会。成功的受训者将代表新一代的科学家, 有助于开发治疗炎症性疾病的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susan Ruth Schwab其他文献

Susan Ruth Schwab的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susan Ruth Schwab', 18)}}的其他基金

FASEB's The Lysophospholipid and Related Mediators Conference: From Bench to Clinic
FASEB 溶血磷脂及相关介质会议:从实验室到临床
  • 批准号:
    10231613
  • 财政年份:
    2021
  • 资助金额:
    $ 32.8万
  • 项目类别:
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2
验证免疫调节鞘氨醇 1-磷酸转运蛋白 SPNS2 的抑制剂
  • 批准号:
    10116274
  • 财政年份:
    2020
  • 资助金额:
    $ 32.8万
  • 项目类别:
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2
验证免疫调节鞘氨醇 1-磷酸转运蛋白 SPNS2 的抑制剂
  • 批准号:
    10348768
  • 财政年份:
    2020
  • 资助金额:
    $ 32.8万
  • 项目类别:
A map of sphingosine 1-phosphate distribution
1-磷酸鞘氨醇分布图
  • 批准号:
    9888299
  • 财政年份:
    2017
  • 资助金额:
    $ 32.8万
  • 项目类别:
Control of sphingosine-1-phosphate distribution.
1-磷酸鞘氨醇分布的控制。
  • 批准号:
    8669540
  • 财政年份:
    2013
  • 资助金额:
    $ 32.8万
  • 项目类别:
Training Program in Immunology and Inflammation
免疫学和炎症培训计划
  • 批准号:
    10610333
  • 财政年份:
    2012
  • 资助金额:
    $ 32.8万
  • 项目类别:
Training Program in Immunology and Inflammation
免疫学和炎症培训计划
  • 批准号:
    10333959
  • 财政年份:
    2012
  • 资助金额:
    $ 32.8万
  • 项目类别:
Training Program in Immunology and Inflammation
免疫学和炎症培训计划
  • 批准号:
    9923520
  • 财政年份:
    2012
  • 资助金额:
    $ 32.8万
  • 项目类别:
Control of sphingosine-1-phosphate distribution.
1-磷酸鞘氨醇分布的控制。
  • 批准号:
    8386910
  • 财政年份:
    2010
  • 资助金额:
    $ 32.8万
  • 项目类别:
Regulation of T cell exit from non-lymphoid tissues
T 细胞从非淋巴组织退出的调节
  • 批准号:
    10660163
  • 财政年份:
    2010
  • 资助金额:
    $ 32.8万
  • 项目类别:

相似海外基金

Understanding how pollutant aerosol particulates impact airway inflammation
了解污染物气溶胶颗粒如何影响气道炎症
  • 批准号:
    2881629
  • 财政年份:
    2027
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Studentship
Nanoengineered hybrid coatings that control inflammation to artificial bone
控制人造骨炎症的纳米工程混合涂层
  • 批准号:
    DP240103271
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Discovery Projects
SARS-CoV-2-induced dead cell fragments drive viral uptake and inflammation
SARS-CoV-2 诱导的死细胞碎片驱动病毒摄取和炎症
  • 批准号:
    DE240101286
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Discovery Early Career Researcher Award
Is extracellular ferritin is an endogenous danger signal that exacerbates inflammation?
细胞外铁蛋白是加剧炎症的内源性危险信号吗?
  • 批准号:
    MR/Y014065/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Research Grant
Does chronic thyroid inflammation explain persistent symptoms in Hashimoto thyroiditis?
慢性甲状腺炎症是否可以解释桥本甲状腺炎的持续症状?
  • 批准号:
    MR/Z503617/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Research Grant
The role of LILRB3-mediated immunomodulation on myeloid cells and exploration of new combination therapy for chronic inflammation and cancer
LILRB3介导的免疫调节对骨髓细胞的作用及慢性炎症和癌症联合治疗的探索
  • 批准号:
    24K18478
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigating the role of synovial glycome in the interplay between systemic and joint inflammation.
研究滑膜糖组在全身炎症和关节炎症之间相互作用中的作用。
  • 批准号:
    MR/Y003551/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Research Grant
SBIR Phase II: Absolute protein quantitation in in vitro diagnostics for gut inflammation
SBIR II 期:肠道炎症体外诊断中的绝对蛋白质定量
  • 批准号:
    2242174
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Cooperative Agreement
Cannabinoids, Inflammation/Infection and Microglia: Relation to Brain and Behaviour
大麻素、炎症/感染和小胶质细胞:与大脑和行为的关系
  • 批准号:
    502602
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
Understanding the link between bone marrow failure and chronic inflammation through the lens of VEXAS syndrome
从 VEXAS 综合征的角度了解骨髓衰竭与慢性炎症之间的联系
  • 批准号:
    MR/Y011945/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.8万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了